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Background
FISH analysis is superior to chromosome analysis in
detecting important prognostic genetic abnormalities in
PCD. However, its sensitivity is hampered due to paucity
of plasma cells in whole bone marrow and often shows
false-negative results when frequency of abnormal cells
is below the cut-off values. Studies have shown that the
abnormality detection rate in enriched plasma cells
(EPC) is greater than unselected plasma cells, but purifi-
cation techniques are limiting to only FISH when bone
marrow volumes are inadequate. The inability to per-
form chromosome analysis may compromise patient
care since chromosome analysis is equally important for
detecting non-plasma cell related abnormalities, such as
secondary myelodysplastic syndrome. To resolve this
critical issue and optimize limited quantity received, we
designed a study where an immuno-magnetic CD138
enriched positive selection of plasma cells was used for
FISH while the negative selection was used to retrieve
the remaining cellular components (RCC) for chromo-
some analysis. After validating this approach in a pilot
study, we implemented this strategy in 2012 for routine
clinical diagnosis in patients with PCD. When there was
adequate sample volume available, both whole bone
marrow and RCC were used for chromosome analysis.
Results
We found 100% success rate for chromosome analysis
using RCC. Identical PCD related genetic abnormalities
were observed by both chromosome analysis using
whole bone marrow and EPC FISH in 4.2% (4/96) cases
while 8.3% (8/96) cases showed discordant results.
Population variants such as loss of Y chromosome were
observed in 6.3% (6/96) cases. Karyotypic abnormalities
of myeloid origin or population variants were found
both in whole bone marrow and RCC cultures. Karyo-
types with PCD related aberrations were seen only in
whole bone marrow cultures in 37.5% of the cases (3/8)
while the remaining 62.5% (5/8) of cases showed them
in both whole bone marrow and RCC cultures. All PCD
related aberrations showed concordant EPC FISH
results.
Conclusions
Our results confirm the feasibility of retrieving RCC
from the CD138 negative fraction, and prove to be an
innovative strategy for performing chromosome analysis
on PCD patients with insufficient sample volumes.
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